Columbia Wanger Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Columbia Wanger Asset Management’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$67M	Sell	1,444,584 -151,750	-10%	-$7.44M	1%	13
2017 Q3	$85M	Buy	1,596,334 +231,900	+17%	+$13.7M	1.26%	10
2017 Q2	$84.7M	Buy	1,364,434 +126,609	+10%	+$7.63M	1.21%	6
2017 Q1	$83.9M	Buy	1,237,825 +62,209	+5%	+$4.74M	1.18%	7
2016 Q4	$82.7M	Sell	1,175,616 -81,655	-6%	-$5.79M	1.16%	11
2016 Q3	$89.2M	Buy	1,257,271 +393,879	+46%	+$25.1M	1.17%	11
2016 Q2	$42.2M	Sell	863,392 -97,753	-10%	-$6.32M	0.49%	91
2016 Q1	$60.9M	Sell	961,145 -150,421	-14%	-$9.84M	0.66%	59
2015 Q4	$125M	Sell	1,111,566 -141,048	-11%	-$14.1M	1.25%	14
2015 Q3	$121M	Sell	1,252,614 -1,081,559	-46%	-$124M	0.96%	20
2015 Q2	$239M	Buy	2,334,173 +89,463	+4%	+$6.95M	1.54%	9
2015 Q1	$139M	Buy	2,244,710 +914,143	+69%	+$50.8M	0.76%	30
2014 Q4	$58.4M	Sell	1,330,567 -460,515	-26%	-$21.1M	0.29%	114
2014 Q3	$101M	Sell	1,791,082 -2,100	-0.1%	-$106K	0.47%	68
2014 Q2	$77.4M	Sell	1,793,182 -2,300	-0.1%	-$94.7K	0.31%	115
2014 Q1	$81.9M	Buy	+1,795,482	New	+$92.4M	0.32%	111

Other funds holding RARE

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Columbia Wanger Asset Management's RARE Position: Q4 2017 in Review

Columbia Wanger Asset Management reduced its Ultragenyx Pharmaceutical (RARE) stake by 9.5% in Q4 2017, selling an estimated $7.44M and leaving 1,444,584 shares worth $67M. The position accounts for 1% of the portfolio, ranked #13.

Columbia Wanger Asset Management first reported a position in RARE in Q1 2014 and has held it in 16 quarters since. The position peaked at $239M in Q2 2015. 163 funds tracked by Wall St. Rank hold RARE as of Q4 2017.

Columbia Wanger Asset Management held 1,444,584 shares of Ultragenyx Pharmaceutical worth $67M as of Q4 2017.
Columbia Wanger Asset Management sold 151,750 Ultragenyx Pharmaceutical shares in Q4 2017, an estimated $7.44M.
Ultragenyx Pharmaceutical made up 1% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #13 holding.
Columbia Wanger Asset Management first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and has held it in 16 quarters since.
Columbia Wanger Asset Management's Ultragenyx Pharmaceutical position peaked at $239M in Q2 2015.
163 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.